Propanc Biopharma Announces Plan to Acquire $100 Million of Ethereum
1. Propanc plans to acquire $100 million in Ethereum over 12 months. 2. Ethereum purchase aims to diversify assets and improve cash flow. 3. CEO highlights Ethereum's advantages over Bitcoin for corporate strategy. 4. Tokenization on Ethereum may enhance liquidity and investor returns. 5. PPCB focuses on biotechnology while leveraging cryptocurrency for growth.